← Back to guidelines
Infectious Disease21 papers

Late congenital syphilis (2 years or more)

Last edited: 4/10/2026

Overview

Late congenital syphilis refers to syphilis diagnosed in children aged 2 years or older who acquired the infection congenitally. This presentation can be asymptomatic or manifest with a variety of signs and symptoms reflecting chronic infection and its sequelae.

Diagnosis

  • Diagnosis relies on a combination of clinical findings, serological tests (treponemal and non-treponemal), and sometimes imaging.
  • Non-treponemal tests (NTTs) are used for screening and monitoring treatment response, while treponemal tests confirm past infection.
  • Point-of-care (POC) tests are available for syphilis diagnosis 1.
  • Management

  • Penicillin G benzathine is the recommended treatment for late congenital syphilis.
  • Azithromycin is excluded as an alternative treatment at any stage of syphilis 1.
  • Special Populations

  • Pregnancy: Pregnant individuals require prompt diagnosis and treatment to prevent congenital syphilis in their offspring.
  • Pediatrics: Management of congenital syphilis in children, including late presentations, is guided by specific pediatric protocols.
  • Key Recommendations

  • Azithromycin should not be used as an alternative treatment for syphilis at any stage 1. (Evidence: Strong)
  • Benzathine penicillin G remains the primary treatment for syphilis 1. (Evidence: Strong)
  • Dual treponemal and non-treponemal point-of-care tests are available for syphilis diagnosis 1. (Evidence: Moderate)
  • References

    1 Janier M, Unemo M, Dupin N, Tiplica GS, Potočnik M, Patel R. 2020 European guideline on the management of syphilis. Journal of the European Academy of Dermatology and Venereology : JEADV 2021. link

    Original source

    1. [1]
      2020 European guideline on the management of syphilis.Janier M, Unemo M, Dupin N, Tiplica GS, Potočnik M, Patel R Journal of the European Academy of Dermatology and Venereology : JEADV (2021)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG